Skip to main content
SpringerLink
Log in

MACC1 overexpression and survival in solid tumors: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Metastasis associated in colon cancer-1 (MACC1) is a newly identified oncogene, and increasing evidence has suggested that its overexpression is associated with the development and progression in many tumors. Here, we perform a meta-analysis to assess the relationship between MACC1 overexpression and survival in solid tumors. Eligible studies were searched in Embase, PubMed, and Web of Science databases up to May 2014. Pooled hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated to estimate the impact of MACC1 overexpression on survival using a random-effect model. A total of 20 eligible studies dealing with various tumors were included in the analysis: 17 were dealing with overall survival (OS), 7 were with relapse-free survival (RFS), and 3 were with disease-free survival (DFS). Combined results suggested a strong link between the high MACC1 expression and the poor overall survival (HR 2.11, 95 % CI 1.59–2.80, P < 0.001). For relapse-free survival, overexpressed MACC1 was also a significant predictor, with a combined HR of 2.22 (95 % CI 1.80–2.74, P < 0.001). Data from the three studies were combined to show that MACC1 overexpression had also an unfavorable impact on disease-free survival (HR 2.94, 95 % CI 1.60–5.38, P < 0.001). Publication bias was not significant. The present meta-analysis showed that overexpression of MACC1 was significantly associated with poorer survival in solid tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kokoszynska K, Krynski J, Rychlewski L, Wyrwicz LS. Unexpected domain composition of MACC1 links met signaling and apoptosis. Acta Biochim Pol. 2009;56:317–23.

    CAS  PubMed  Google Scholar 

  2. Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, et al. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS One. 2012;7:e49249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kawamura M, Saigusa S, Toiyama Y, Tanaka K, Okugawa Y, Hiro J, et al. Correlation of MACC1 and met expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res. 2012;32:1527–31.

    CAS  PubMed  Google Scholar 

  4. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15:59–67.

    Article  CAS  PubMed  Google Scholar 

  5. Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, et al. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg. 2012;256:763–71. discussion 771.

    Article  PubMed  Google Scholar 

  6. Isella C, Mellano A, Galimi F, Petti C, Capussotti L, De Simone M, et al. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg. 2013;257:1089–95.

    Article  PubMed  Google Scholar 

  7. Ge SH, Wu XJ, Wang XH, Xing XF, Zhang LH, Zhu YB, et al. Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients. Chin J Cancer Res. 2011;23:153–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Guo T, Yang J, Yao J, Zhang Y, Da M, Duan Y. Expression of MACC1 and c-Met in human gastric cancer and its clinical significance. Cancer Cell Int. 2013;13:121.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wang L, Wu Y, Lin L, Liu P, Huang H, Liao W, et al. Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer. 2013;133:1419–30.

    Article  CAS  PubMed  Google Scholar 

  10. Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, et al. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2012;18:2995–3003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z, et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One. 2013;8:e64235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, et al. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med. 2013;11:41.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li C, et al. MACC1 expression correlates with PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer Prev. 2014;15:999–1003.

    Article  PubMed  Google Scholar 

  14. Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, et al. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci. 2014;11:268–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 2011;31:1141–5.

    PubMed  Google Scholar 

  16. Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L, et al. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer. Med Oncol. 2014;31:790.

    Article  PubMed  Google Scholar 

  17. Zhu M, Xu Y, Mao X, Gao Y, Shao L, Yan F. Overexpression of metastasis-associated in colon cancer-1 associated with poor prognosis in patients with esophageal cancer. Pathol Oncol Res. 2013;19:749–53.

    Article  CAS  PubMed  Google Scholar 

  18. Zhang K, Zhang Y, Zhu H, Xue N, Liu J, Shan C, Zhu Q, et al. High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumour Biol 2014;35:1343-50.

  19. Yang T, Kong B, Kuang YQ, Cheng L, Gu JW, Zhang JH, et al. Overexpression of MACC1 protein and its clinical implications in patients with glioma. Tumour Biol. 2014;35:815–9.

    Article  CAS  PubMed  Google Scholar 

  20. Hagemann C, Fuchs S, Monoranu CM, Herrmann P, Smith J, Hohmann T, et al. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Neurol Oncol. 2013;15:1696–709.

    Article  Google Scholar 

  21. Wang Y, Hong Q, Wang J, Fang Y, Hu C. Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion. Tumour Biol. 2014;35:3771–8.

    Article  CAS  PubMed  Google Scholar 

  22. Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye C, et al. Overexpression of macc1 and its significance in human breast cancer progression. Cell Biosci. 2013;3:16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000

  24. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.

    Article  CAS  PubMed  Google Scholar 

  25. Handoll HH. Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil. 2006;87:875.

    Article  PubMed  Google Scholar 

  26. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ Br Med J. 2007;335:914.

    Article  Google Scholar 

  27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.

    Article  CAS  PubMed  Google Scholar 

  28. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol. 2009;41:2356–9.

    Article  CAS  PubMed  Google Scholar 

  30. Canadas I, Taus A, Gonzalez I, Villanueva X, Gimeno J, Pijuan L, et al. High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients. Oncotarget. 2014;5:5246–56.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Zhang K, Tian F, Zhang Y, Zhu Q, Xue N, Zhu H, Wang H, Guo X, et al. MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol 2014;35:2537-48.

  32. Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett. 2012;4:783–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Meng F, Li H, Shi H, Yang Q, Zhang F, Yang Y, et al. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway. PLoS One. 2013;8:e60821.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhang K, Tian F, Zhang Y, Zhu Q, Xue N, Zhu H, et al. MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumour Biol. 2014;35:2537–48.

    Article  CAS  PubMed  Google Scholar 

  35. Ocana A, Vera-Badillo F, Seruga B, Templeton A, Pandiella A, Amir E. Her3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst. 2013;105:266–73.

    Article  CAS  PubMed  Google Scholar 

  36. Pichorner A, Sack U, Kobelt D, Kelch I, Arlt F, Smith J, et al. In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice. Clin Exp Metastasis. 2012;29:573–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the National Natural Science Foundation of China (nos.81372210).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Colorectal Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China

    Gang Wang, Zhixuan Fu & Dechuan Li

Authors
  1. Gang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhixuan Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dechuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dechuan Li.

Additional information

Gang Wang and Zhixuan Fu contributed equally.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, G., Fu, Z. & Li, D. MACC1 overexpression and survival in solid tumors: a meta-analysis. Tumor Biol. 36, 1055–1065 (2015). https://doi.org/10.1007/s13277-014-2736-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2736-9

Keywords

Search

Navigation